PEG–lipid micelles as drug carriers: physiochemical attributes, formulation principles and biological implication
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
PEG–lipid micelles as drug carriers: physiochemical attributes, formulation principles and biological implication
Authors
Keywords
-
Journal
JOURNAL OF DRUG TARGETING
Volume 23, Issue 3, Pages 222-231
Publisher
Informa UK Limited
Online
2014-12-30
DOI
10.3109/1061186x.2014.997735
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- pH-sensitive poly(histidine)-PEG/DSPE-PEG co-polymer micelles for cytosolic drug delivery
- (2012) Hong Wu et al. BIOMATERIALS
- Mixed micelles of PEG2000-DSPE and vitamin-E TPGS for concurrent delivery of paclitaxel and parthenolide: Enhanced chemosenstization and antitumor efficacy against non-small cell lung cancer (NSCLC) cell lines
- (2012) Kanwaldeep K. Gill et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Anticancer nanomedicine and tumor vascular permeability; Where is the missing link?
- (2012) Sebastien Taurin et al. JOURNAL OF CONTROLLED RELEASE
- Biocompatibility of engineered nanoparticles for drug delivery
- (2012) Sheva Naahidi et al. JOURNAL OF CONTROLLED RELEASE
- Raman Microscopy for Noninvasive Imaging of Pharmaceutical Nanocarriers: Intracellular Distribution of Cationic Liposomes of Different Composition
- (2012) T. Chernenko et al. MOLECULAR PHARMACEUTICS
- Pharmacokinetic Evaluation of a DSPE-PEG2000 Micellar Formulation of Ridaforolimus in Rat
- (2012) Connie Remsberg et al. Pharmaceutics
- PEO-PPO Block Copolymers for Passive Micellar Targeting and Overcoming Multidrug Resistance in Cancer Therapy
- (2011) C. Alvarez-Lorenzo et al. CURRENT DRUG TARGETS
- Clathrin-independent endocytosis: mechanisms and function
- (2011) Kirsten Sandvig et al. CURRENT OPINION IN CELL BIOLOGY
- Paclitaxel loaded PEG5000–DSPE micelles as pulmonary delivery platform: Formulation characterization, tissue distribution, plasma pharmacokinetics, and toxicological evaluation
- (2011) Kanwaldeep K. Gill et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Shape-specific polymeric nanomedicine: emerging opportunities and challenges
- (2011) Li Tao et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- Rehydrated sterically stabilized phospholipid nanomicelles of budesonide for nebulization: physicochemical characterization and in vitro, in vivo evaluations
- (2011) Mohanad Sahib et al. International Journal of Nanomedicine
- Multi-drug delivery to tumor cells via micellar nanocarriers
- (2011) Usha Katragadda et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Pegylated Phosphotidylethanolamine Inhibiting P-Glycoprotein Expression and Enhancing Retention of Doxorubicin in MCF7/ADR Cells
- (2011) Jing Wang et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect
- (2010) Jun Fang et al. ADVANCED DRUG DELIVERY REVIEWS
- Targeted delivery of RGD-modified liposomes encapsulating both combretastatin A-4 and doxorubicin for tumor therapy: In vitro and in vivo studies
- (2010) Yi-fei Zhang et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- pH-sensitive PEG-based micelles for tumor targeting
- (2010) Stefano Salmaso et al. JOURNAL OF DRUG TARGETING
- Multifunctionality of lipid-core micelles for drug delivery and tumour targeting
- (2010) Rupa R. Sawant et al. MOLECULAR MEMBRANE BIOLOGY
- Paclitaxel-Loaded Polymeric Micelles Modified with MCF-7 Cell-Specific Phage Protein: Enhanced Binding to Target Cancer Cells and Increased Cytotoxicity
- (2010) Tao Wang et al. MOLECULAR PHARMACEUTICS
- Combined Chemo-immunotherapy as a Prospective Strategy To Combat Cancer: A Nanoparticle Based Approach
- (2010) Aniruddha Roy et al. MOLECULAR PHARMACEUTICS
- Nanomedicinal strategies to treat multidrug-resistant tumors: current progress
- (2010) Xiaowei Dong et al. Nanomedicine
- In vitro cytotoxicity of novel pro-apoptotic agent DM-PIT-1 in PEG-PE-based micelles alone and in combination with TRAIL
- (2009) Igor Skidan et al. DRUG DELIVERY
- Overcoming the barriers in micellar drug delivery: loading efficiency,in vivostability, and micelle–cell interaction
- (2009) Sungwon Kim et al. Expert Opinion on Drug Delivery
- Enhanced cytotoxicity of TATp-bearing paclitaxel-loaded micelles in vitro and in vivo
- (2009) Rupa R. Sawant et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- 9-NC-loaded folate-conjugated polymer micelles as tumor targeted drug delivery system: Preparation and evaluation in vitro
- (2009) Xue Han et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Effect of the Lipid Chain Melting Transition on the Stability of DSPE-PEG(2000) Micelles
- (2009) Mark Kastantin et al. LANGMUIR
- Tyrosine polyethylene glycol (PEG)-micelle magnetic resonance contrast agent for the detection of lipid rich areas in atherosclerotic plaque
- (2009) Anne Beilvert et al. MAGNETIC RESONANCE IN MEDICINE
- Mixed PEG–PE/vitamin E tumor-targeted immunomicelles as carriers for poorly soluble anti-cancer drugs: Improved drug solubilization and enhanced in vitro cytotoxicity
- (2008) R SAWANT et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Polymeric Micelles Modified by Folate-PEG-Lipid for Targeted Drug Delivery to Cancer Cells In Vitro
- (2008) Akihiro Hayama et al. JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY
- PEG-PE Micelles Loaded with Paclitaxel and Surface-Modified by a PBR-Ligand: Synergistic Anticancer Effect
- (2008) Tiziana Musacchio et al. MOLECULAR PHARMACEUTICS
- Preparation and properties of mixed micelles made of Pluronic polymer and PEG-PE
- (2007) Lingbing Li et al. JOURNAL OF COLLOID AND INTERFACE SCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More